Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norfloxacin added to cefotaxime for spontaneous bacterial peritonitis in cirrhosis
2008-005503-26Phase 4Active
- Sponsor
- José Such Ronda
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in primary peritonitis and Cirrhosis comparing Norfloxacin + cefotaxime with Placebo + cefotaxime (2 arms). Primary endpoint: All-cause mortality during hospitalization. Started Mar 2009; status: active.
02
Drugs
norfloxacincefotaxime
03
Conditions
primary peritonitisCirrhosis
Beyond the preview
Go deeper on 2008-005503-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005503-26.